Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$410,037
-$73,872 QoQ
Shares Held
88,180
-2.0% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#46
of 125 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aldebaran Capital, LLC holds $7,545,514 across 6 Biotechnology names. AVIR ranks #4 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACRS |
Aclaris Therapeutics, Inc.
|
936,731 | $4,955,306 | |
| 2 | TECX |
Tectonic Therapeutic, Inc.
|
36,797 | $1,265,080 | |
| 3 | PMVP |
PMV Pharmaceuticals, Inc.
|
467,432 | $626,358 | |
| 4 | AVIR |
Atea Pharmaceuticals, Inc.
This page
|
88,180 | $410,037 | |
| 5 | OKUR |
OnKure Therapeutics, Inc.
|
39,869 | $181,802 | |
| 6 | IMA |
ImageneBio, Inc.
|
18,124 | $106,931 |
All Filings in AVIR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $410,037 | 88,180 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $483,909 | 89,946 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $323,188 | 90,529 | Shares | Sole | 2026-02-12 | |
| 2025-03-31 | $112,125 | 37,500 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||